BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22734211)

  • 21. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Maruyama Y; Kishi S
    Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes of retinal structure after systemic immunosuppressive treatment in eyes with Vogt-Koyanagi-Harada disease].
    Cao XS; Zhang YP; Ji HX; Jiao X; Wang H
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(22):1725-1729. PubMed ID: 32536094
    [No Abstract]   [Full Text] [Related]  

  • 23. FEATURES OF OPTICAL COHERENCE TOMOGRAPHY FOR THE DIAGNOSIS OF VOGT-KOYANAGI-HARADA DISEASE.
    Liu XY; Peng XY; Wang S; You QS; Li YB; Xiao YY; Jonas JB
    Retina; 2016 Nov; 36(11):2116-2123. PubMed ID: 27145255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Depth SD-OCT Images Reveal Characteristic Choroidal Changes in Patients With Vogt-Koyanagi-Harada Disease.
    Li M; Liu Q; Luo Y; Li Y; Lin S; Lian P; Yang Q; Li X; Liu X; Sadda S; Lu L
    Ophthalmic Surg Lasers Imaging Retina; 2016 Nov; 47(11):1004-1012. PubMed ID: 27842195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultra-wide-field angiography findings in acute Vogt-Koyanagi-Harada disease.
    Kim P; Sun HJ; Ham DI
    Br J Ophthalmol; 2019 Jul; 103(7):942-948. PubMed ID: 30100554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease.
    Kuo IC; Rechdouni A; Rao NA; Johnston RH; Margolis TP; Cunningham ET
    Ophthalmology; 2000 Sep; 107(9):1721-8. PubMed ID: 10964836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Choroidal excavation in vogt-koyanagi-harada disease.
    Hashida N; Fok A; Nishida K
    Case Rep Ophthalmol; 2014 May; 5(2):222-5. PubMed ID: 25202266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Optical coherence tomography angiography of acute Vogt-Koyanagi-Harada disease].
    Jia SS; Zhao C; Gong D; Chen Z; Zhang MF
    Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):735-739. PubMed ID: 29050185
    [No Abstract]   [Full Text] [Related]  

  • 29. PREDICTIVE ROLE OF SWEPT SOURCE OCT ANGIOGRAPHY IN RELAPSING VOGT-KOYANAGI-HARADA DISEASE.
    Interlandi E; Pellegrini F; Papayannis A; Latanza L; Pece A; Pavesio C
    Retin Cases Brief Rep; 2023 Jul; 17(4):414-418. PubMed ID: 35880955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
    Tsujikawa A; Yamashiro K; Yamamoto K; Nonaka A; Fujihara M; Kurimoto Y
    Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.
    Lertsumitkul S; Whitcup SM; Nussenblatt RB; Chan CC
    Graefes Arch Clin Exp Ophthalmol; 1999 Dec; 237(12):1039-45. PubMed ID: 10654175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
    Abouammoh MA; Gupta V; Hemachandran S; Herbort CP; Abu El-Asrar AM
    Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
    Lee GE; Lee BW; Rao NA; Fawzi AA
    Ocul Immunol Inflamm; 2011 Feb; 19(1):42-7. PubMed ID: 21034311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Enhanced Depth Imaging and Swept Source Optical Coherence Tomography in Assessment of Choroidal Thickness in Vogt-Koyanagi-Harada Disease.
    Chee SP; Chan SN; Jap A
    Ocul Immunol Inflamm; 2017 Aug; 25(4):528-532. PubMed ID: 27070488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
    Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
    Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photoreceptor Cell Injury Starts in the Initial Stage of Vogt-Koyanagi-Harada Disease.
    Zhu R; Zhang J; Qiao L; Zhang Y; Gu X; Yang L
    Ocul Immunol Inflamm; 2018; 26(6):934-942. PubMed ID: 28323511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease.
    Jap A; Chee SP
    Br J Ophthalmol; 2017 Feb; 101(2):186-189. PubMed ID: 27048179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vogt-Koyanagi-Harada disease following BCG vaccination and tuberculosis.
    Dogan B; Erol MK; Cengiz A
    Springerplus; 2016; 5():603. PubMed ID: 27247899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
    Nazari H; Rao NA
    Br J Ophthalmol; 2012 Nov; 96(11):1410-4. PubMed ID: 22942161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids.
    Hirooka K; Saito W; Namba K; Mizuuchi K; Iwata D; Hashimoto Y; Ishida S
    BMC Ophthalmol; 2015 Dec; 15():181. PubMed ID: 26677974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.